The GRIN2D gene (Glutamate Ionotropic Receptor NMDA Type Subunit 2D) encodes the GluN2D subunit of N-methyl-D-aspartate (NMDA) receptors, a critical subtype of ionotropic glutamate receptors in the central nervous system. NMDA receptors are ligand-gated calcium channels that play essential roles in synaptic transmission, plasticity, and survival. The GluN2D subunit confers distinct pharmacological and electrophysiological properties to NMDA receptors and is particularly important in brain regions involved in motor control, cognition, and neurodegeneration.
| Attribute |
Value |
| Gene Symbol |
GRIN2D |
| Full Name |
Glutamate Ionotropic Receptor NMDA Type Subunit 2D |
| Chromosomal Location |
19q13.12 |
| NCBI Gene ID |
2904 |
| Ensembl ID |
ENSG00000182308 |
| UniProt ID |
Q9UQF8 |
| Gene Type |
Protein coding |
| OMIM |
604397 |
The GluN2D protein is a transmembrane receptor subunit that assembles with other NMDA receptor subunits (GluN1, GluN2A-C, GluN3A-B) to form functional receptor complexes. The receptor is a heterotetramer typically composed of two GluN1 subunits and two GluN2 subunits. GluN2D-containing receptors have distinct developmental and regional expression patterns.
- Extracellular Domain: Ligand-binding domain for glutamate and co-agonists
- Transmembrane Segments: Four α-helices that form the ion channel pore
- C-terminal Domain: Intracellular tail involved in scaffolding and signaling
- S1 and S2 Regions: Form the agonist binding domain
GluN2D-containing NMDA receptors have unique functional properties:
- Calcium Permeability: High calcium influx through these receptors
- Slow Decay Kinetics: Longer channel open times compared to other GluN2 subunits
- Mg²⁺ Block Sensitivity: Reduced voltage-dependent magnesium block
- Regional Expression: High expression in basal ganglia, hypothalamus, and olfactory bulb
- Ca²⁺/Calmodulin-Dependent Pathways: Activation of downstream enzymes
- CaMKII Activation: Calcium-dependent protein kinase signaling
- CREB Activation: Transcriptional regulation via cAMP response element-binding protein
- Synaptic Plasticity: Role in long-term potentiation and depression
GRIN2D is implicated in AD pathophysiology:
- NMDA receptor dysfunction contributes to synaptic failure
- Altered GluN2D expression in AD brains
- Excitotoxicity through excessive calcium influx
- Interactions with amyloid-beta signaling
The gene has particular relevance to PD:
- High expression in basal ganglia regions affected in PD
- Modulation of dopaminergic signaling
- NMDA receptor antagonists have therapeutic potential
- Role in levodopa-induced dyskinesias
- Huntington's Disease: Altered NMDA receptor function
- Epilepsy: GRIN2D mutations associated with seizure disorders
- Schizophrenia: Genetic associations with psychiatric disorders
- Stroke: Excitotoxic cell death via NMDA receptors
| Mutation |
Type |
Effect |
| A716V |
Missense |
Constitutive activation |
| P1419L |
Missense |
Altered channel properties |
- Various SNPs have been associated with neurological disease risk
- Studies link GRIN2D variants to schizophrenia susceptibility
- Gene-environment interactions are being investigated
- NMDA Receptor Modulators: Compounds that selectively modulate GluN2D-containing receptors
- Channel Blockers: Ifenprodil and related compounds show selectivity
- Allosteric Modulators: Positive and negative allosteric modulators
- Ifenprodil: NR2B-selective antagonist (less relevant for GluN2D)
- E体202: GluN2D-selective antagonist in development
- CIQ: Positive allosteric modulator of GluN2D
- Neuroprotective strategies targeting excitotoxicity
- Treatment of movement disorders
- Potential for preventing neurodegeneration
| Subunit |
Role |
| GRIN1 (GluN1) |
Required subunit |
| GRIN2D (GluN2D) |
Modulatory subunit |
| GRIN3A (GluN3A) |
Regulatory subunit |
- PSD-95: Scaffold protein at postsynaptic密度
- CaMKII: Calcium-dependent kinase
- SynGAP: Synaptic Ras GTPase-activating protein
- Shank: Postsynaptic density scaffolding proteins
- PI3K/Akt pathway
- MAPK/ERK pathway
- PLCγ signaling
Current research focuses on:
- Developing GluN2D-selective pharmacological tools
- Understanding regional specificity of GluN2D function
- Exploring neuroprotective strategies
- Genetic studies linking GRIN2D to disease